Roche, Hologic, Cepheid nab FDA clearances for STI tests by Conor Hale Friday, May 24, 2019 The FDA cleared a handful of diagnostics aimed at STIs, including the first to detect chlamydia and gonorrhea outside the genitals.
Hologic unveils new mammography management software by Conor Hale Wednesday, February 13, 2019 Hologic launched management software for its mammography machines that can predict the failure of X-ray hardware and help schedule early replacements.
Hologic adds Focal Therapeutics to breast surgery set for $125M by Conor Hale Friday, September 28, 2018 Hologic is acquiring Focal Therapeutics for $125 million in cash to supplement its breast-conserving surgery franchise.
Chutes & Ladders—Cell Medica names Kite's European chief as CEO by Conor Hale Friday, August 3, 2018 CAR-T maker Cell Medica names Kite’s European chief as CEO; Oncorus poaches a Moderna cancer executive; and Achaogen axes R&D and its C-suite.
Hologic’s stock dips despite strong quarterly earnings by Conor Hale Thursday, August 2, 2018 Hologic’s stock stumbled despite higher-than-expected earnings, following the departure of its CFO and an FDA letter to its aesthetics arm, Cynosure.
Hologic makes $732M write-down as $1.6B deal hits turbulence by Nick Paul Taylor Friday, May 4, 2018 Hologic now expects full-year sales at the unit to be “down materially” on the $390 million it posted in the four quarters starting October 2016.
Heartflow's noninvasive CAD test covered in California, Alabama—News of Note by Amirah Al Idrus Friday, September 1, 2017 Here's Friday's medtech news of note.
Hologic picks up medical aesthetics player Cynosure in $1.6B+ deal by Amirah Al Idrus Tuesday, February 14, 2017 Diagnostics player Hologic is diving into medical aesthetics with an acquisition of Cynosure worth approximately $1.65 billion.
